Leash Bio builds massive protein-molecule datasets and trains machine learning models to design new medicinal compounds and accelerate drug discovery.
What it is
Leash Bio is a drug discovery approach that combines massive proprietary datasets with machine learning models. By screening millions of chemical compounds against thousands of proteins, the company generates billions of data points used to design and refine novel chemical matter.
Key features
- Massive dataset of over thirty billion protein-molecule interactions measured
- Cyclical engine running data collection and machine learning iterations every few months
- Software designed to build and refine new chemical molecules with targeted activities
- Screening capacity of ninety-six per week across more than seven hundred protein targets
- Internal drug development programs focused on oncology targets
- Collaborative partnerships with biopharma organizations to explore new molecule opportunities
Who it's for
Leash Bio is intended for biopharmaceutical researchers, medicinal chemists, and drug discovery teams looking to utilize large-scale biochemical data and machine learning.
Pricing
Check the official website for current pricing.
Use cases
- Screen chemical compounds against protein targets
- Train machine learning models for drug design
- Generate biochemical interaction measurements
Categories:
Similar to Leash Bio
More Leash Bio alternatives
Profluent
OtherAuthor novel proteins and gene editors using AI
Profluent uses machine learning models to author new proteins and gene editors from scratch for therapeutics and industrial applications.
